Expression of ADAM9 (meltrin-γ) around aseptically loosened total hip replacement implants

Rheumatology

Volumn 45, Issue 7, 2006, Pages 808-814

  Ma, G F ^a   Liljestrom M ^b   Ainola, M ^b   Chen, T ^a   Tiainen, V M ^c   Lappalainen, R ^d   Konttinen, Y T ^a,c,e   Salo, J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e COXA Hospital for Joint Replacement ^*  (Finland)

Author keywords

ADAM9; Aseptic loosening; Fusion molecule; Multinucleated giant cells; Total hip replacement

Indexed keywords

CD68 ANTIGEN; COLONY STIMULATING FACTOR 1; DISINTEGRIN; MELTRIN GAMMA; MESSENGER RNA; METALLOPROTEINASE; METALLOPROTEINASE ADAM9; OSTEOCLAST DIFFERENTIATION FACTOR; POLY(METHYL METHACRYLATE); TISSUE EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE DESTRUCTION; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOPROSTHESIS LOOSENING; FEMALE; FLOW CYTOMETRY; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; MORPHOMETRICS; MULTINUCLEAR CELL; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOTAL HIP PROSTHESIS; WESTERN BLOTTING;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BONE CEMENTS; CARRIER PROTEINS; CELLS, CULTURED; FEMALE; GIANT CELLS, FOREIGN-BODY; HIP PROSTHESIS; HUMANS; IMMUNOENZYME TECHNIQUES; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; POLYMETHYL METHACRYLATE; PROSTHESIS FAILURE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SYNOVIAL MEMBRANE;

EID: 33745590712     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel003     Document Type: Article

References (30)

1. Goodman SB, Lind M, Song Y, Smith RL. In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop 1998; 352:25-34.
2. Lassus J, Salo J, Jiranek WA et al. Macrophage activation results in bone resorption. Clin Orthop 1998;352:7-15.
3. Ma J, Chen T, Mandelin J et al. Regulation of macrophage activation. Cell Mol Life Sci 2003;60:2334-46.
4. Goldring SR, Jasty M, Roelke MS, Rourke CM, Bringhurst FR, Harris WH. Formation of a synovial-like membrane at the bone-cement interface. Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum 1986;29: 836-42.
5. Black RA, White JM. ADAMs: Focus on the protease domain. Curr Opin Cell Biol 1998;10:654-9.
6. Zhu X, Evans JP. Analysis of the roles of RGD-binding integrins, alpha(4)/alpha(9) integrins, alpha(6) integrins, and CD9 in the interaction of the fertilin beta (ADAM2) disintegrin domain with the mouse egg membrane. Biol Reprod 2002;66:1193-202.
7. Iba K, Albrechtsen R, Gilpin B et al. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol 2000;149:1143-56.
8. Abe E, Mocharla H, Yamate T, Taguchi Y, Manolagas SC. Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif Tissue Int 1999;64:508-15.
9. Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 2003;17:7-30.
10. Mandelin J, Li TF, Hukkanen MV et al. Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses. J Rheumatol 2003;30:2033-8.
11. Namba K, Nishio M, Mori K et al. Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell Immunol 2001;213:104-13.
12. Paloneva J, Mandelin J, Kiialainen A et al. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 2003;198:669-75.
13. Santavirta S, Konttinen YT, Hoikka V, Eskola A. Immunopathological response to loose cementless acetabular components. J Bone Joint Surg Br 1991;73:38-42.
14. Xu JW, Konttinen YT, Waris V, Pätiälä H, Sorsa T, Santavirta S. Macrophage-colony stimulating factor (M-CSF) is increased in the synovial-like membrane of the periprosthetic tissues in the aseptic loosening of total hip replacement (THR). Clin Rheumatol 1997;16:243-48.
15. Mandelin J, Li TF, Liljeström M et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Br 2003;85-B:1196-201.
16. Ritchlin CT, Schwarz EM, O'Keefe RJ, Looney RJ. RANK, RANKL and OPG in in.ammatory arthritis and periprosthetic osteolysis. J Musculoskelet Neuronal Interact 2004;4:276-84.
17. Tanaka S, Takahashi N, Udagawa N et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91: 257-63.
18. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 1998;188:997-1001.
19. Haynes DR, Crotti TN, Potter AE et al. The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 2001;83:902-11.
20. Roodman GD. Cell biology of the osteoclast. Exp Hematol 1999;27:1229-41.
21. Blobel CP, White JM. Structure, function and evolutionary relationship of proteins containing a disintegrin domain. Curr Opin Cell Biol 1992;4:760-5.
22. Martin I, Epand RM, Ruysschaert JM. Structural properties of the putative fusion peptide of fertilin, a protein active in sperm-egg fusion, upon interaction with the lipid bilayer. Biochemistry 1998; 37:17030-9.
23. Felix R, Cecchini MG, Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology 1990;127:2592-4.
24. Huang S, Endo RI, Nemerow GR. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995;69:2257-63.
25. Zhou M, Graham R, Russell G, Croucher PI. MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin. Biochem Biophys Res Commun 2001; 280:574-80.
26. Weskamp G, Kratzschmar J, Reid MS, Blobel CP. MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol 1996;132:717-26.
27. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995;7:728-35.
28. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995;375:244-7.
29. Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ. ADAM-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 2002;41:15394-403.
30. Wolfsberg TG, Bazan JF, Blobel CP, Myles DG, Primakoff P, White JM. The precursor region of a protein active in sperm-egg fusion contains a metalloprotease and a disintegrin domain: Structural, functional, and evolutionary implications. Proc Natl Acad Sci USA 1993;90:10783-7.